Angela B. Kodsi, Pharm.D. is the Rare Neuroscience Medical Affairs Director with Pfizer Pharmaceuticals. Dr. Kodsi received her Doctor of Pharmacy from the University of North Carolina at Chapel Hill. She completed both her Residency and Fellowship in Psychopharmacology at the VA San Diego Healthcare System. Since joining pharmaceutical industry over 20 years ago, Dr. Kodsi has provided field medical support in the areas of Psychiatry, Neurology, Neuroscience, and Women’s and Men’s Health. Dr. Kodsi also served as the North American External Excellence Lead for Pfizer over the past 4 years. Dr. Kodsi is the author of several scientific articles, book chapters and published abstracts.

Lisa Ambrosini Vadola is currently a Manager of Medical Writing at Whitsell Innovations, Inc, where she leads a team of medical writers and supports clients in the pharmaceutical and biotechnology industries with the preparation of clinical regulatory documents, including submissions to global regulatory agencies. In addition, Lisa provides consultation and training in regulatory medical writing. Before joining Whitsell Innovations, Inc., Lisa earned a PhD in Chemistry from Columbia University and completed postdoctoral training in the Laboratory of Chemical Biology and Microbial Pathogenesis at the Rockefeller University.

Kevin Appareti is Senior Director, Global Medical Science Liaison in the Chief Medical Office at Royal Philips. He leads the Key Opinion Leader Program and Medical Education Program. He works across Philips’ businesses, markets, and research to build strong internal and external relationships with Key Opinion Leaders (KOLs) and influencers. Kevin partners with internal business, market, and research leaders and external KOLs to develop Strategic KOL Engagement Programs to deliver strategic guidance, leverage clinical and scientific knowledge, foster peer-to-peer relationships, and support clinical and marketing evidence development and medical education in support of Philips development of meaningful innovations.

In her 25+ years of industry experience, Lynn has served in both individual and leadership positions within Medical Affairs at both large and start-up companies. She is currently Sr. Director, Medical Science Liaisons at BridgeBio, where she is building and leading a field medical team in the rare cardiovascular therapeutic area. Lynn is a transformative leader with proven excellence in building & developing high performing teams. Along with her leadership positions, Lynn is very active in growing/expanding the MSL profession across the industry and is a frequent invited speaker. She has also authored/ co-authored several MSL surveys highlighting and assessing the MSL role.

Donna V. Booth, B.S, PharmD. is the Head of Field Medical Accounts (East) at GlaxoSmithKline. She has extensive experience across Medical Affairs in various leadership and strategy roles including Medical Information, HEOR and Field Medical. She currently leads a team of field liaisons focused on medical engagements related to clinical, economic and humanistic topics with Population Based Decision Makers at Payers and Health Systems. Donna received her Bachelor of Pharmacy from University of Georgia & her Doctor of Pharmacy from Medical University of South Carolina. Before joining industry, Donna was a clinical pharmacist with faculty appointments at local colleges of pharmacy.

Dannis Chang, PharmD., is currently the Hematology Medical Communications Team Lead at Genentech Inc, where he leads the strategic development, planning, and delivery of scientific content, as well as enabling timely, relevant, personalized, accurate, balanced, and impactful communication of clinical information or scientific evidence to customers to enhance their experiences, support improved patient outcomes, and foster an ongoing connection aimed at maximizing medical progress.  He received a doctorate of pharmacy degree from University of Southern California and a post-doctoral fellowship from Rutgers University.

Ed Cunningham, PharmD is Senior Director, Neurology Medical Science Liaison (MSL) Team Lead at Sunovion Pharmaceuticals Inc. Ed is based in Milwaukee, WI, and is responsible for overseeing the US Neurology MSL team. Prior to joining Sunovion, Ed was the Director of Specialty Care MSLs at Eisai Inc., leading the company’s Neuroscience and Metabolic MSL teams. Ed obtained his PharmD degree from Philadelphia College of Pharmacy and completed a 1-year Drug Information Residency with Janssen Pharmaceutica. Ed has been in the pharmaceutical industry for 17 years, working as a team leader in a variety of Medical Affairs functions, including Medical Information, Medical Education, Investigator Initiated Studies, and MSLs.

Hanady has 15 years of experience in Medical Affairs and Medical Information. She currently leads the Global Customer Engagement team at Bristol Myers Squibb. Hanady is an executive board member of the phactMI Board of Directors. Prior to BMS, Hanady worked with large and mid-size pharmaceutical companies in a variety of roles, always with a focus on simplification, standardization, and innovation.

Dr. Sarah Ellinwood is an associate analyst and medical writer at Verge Scientific Communications in Tysons, VA, where she works primarily with up-and-coming biotechnology companies to develop and craft their messaging and scientific stories. Prior to joining Verge, she was a regulatory medical writer at Technical Resources International in Bethesda, MD. She received her PhD in Molecular and Cellular Biology from the University of Maryland in 2017. Currently, she also serves as the National Communications Vice-Chair for Women In Bio, a nonprofit organization aimed at supporting women in the life sciences.

Maureen has over 20 years of experience in Medical Affairs, including leadership roles in Medical Information, Medical Communications, and Field Medical. Maureen has been with Takeda for 9 years. She is currently Vice President Medical and Scientific Communications at Takeda. Previously, Maureen was Head of Global Medical Communications at Shire. Maureen has served on various DIA program committees. Prior to Takeda, Maureen held various positions of increasing responsibility including, Director of Medical Information at GlaxoSmithKline and Head of Medical Services at Incyte. Maureen has 10 years of clinical practice and teaching experience at Thomas Jefferson University Hospital and the University of the Sciences in Philadelphia.

Dr. Galici has a background in Drug Discovery and Clinical Development with expertise in Pharmacology. He has over 15 years of experience successfully and strategically planning and delivering scientific, medical communications and global regulatory submissions to support Oncology, Vaccine, Rare Disease, Neuroscience, Pain, Immunology and Inflammation, and Consumer Health (nutrition, Rx-to-OTC switch) programs. He is currently the co-chair of the DIA MASC forum.

Alex Kantar is an Associate Director within Specialty at AbbVie. She has over 15 years of experience in Medical Information where she has worked in a variety of therapeutic areas supporting products in all phases of their lifecycle, from preclinical to mature products. In addition, she has led several initiatives spanning topics such as globalization, content harmonization, launch excellence, and medical booth excellence. Most recently, her role was expanded within Global Medical Communications to also include management and oversight of Publications. Alex obtained her PharmD degree from Purdue University.

Life sciences R&D Ecosystem Expert, Independent Small Business and Workforce Advocate, Software Platform Developer and Investor. Focus areas include: Regulatory and Clinical Operations, Strategic Patient Engagement, CMC, Real World Evidence, Pharmacovigilance, and Biometrics, Medical Affairs, Market Research, Medical Writing, Data Management, Discovery, Toxicology, Pharmacometrics and Pharmacology, and all of the technology that enables these functional areas, others. Actively creating crypto for organizations in the form of LifeSciHub, a nascent Decentralized Autonomous Organization. Exactly how crypto has upended traditional currency in incredible ways, DAO is a new way that groups can create value outside of hierarchical structure.

As a founding partner of Global Life Sciences Alliance, our focus is on working with Sponsors and CROs to leverage the GLSA network of solution providers to accelerate clinical trials to meet study milestones and successfully complete trials. Chris has over 25 years of experience in clinical research business development. He has focused on clinical trial technologies while working in large CROs and select eclinical technology companies. Chris establishes strong working relationships with customers and co-workers and has built a significant network of contacts. Connecting people for their mutual benefit is his passion.

David Meats is a Director of Regulatory Services and Medical Affairs at Certara. He has been a medical writer and manager for 23 years working in oncology, immuno-oncology, endocrinology, musculoskeletal, cardiac, hepatic, renal, and infectious disease therapeutic areas on nearly every available clinical document type. He specializes in leading and writing FDA and EMA regulatory submissions and an expert in technology development in regulatory services. David is also a co-chair for the Medical Writing track of the DIA 2024 conference, and has been a member of DIA for 8 years.

Ms. Meyers is a Senior Vice President at Syneos Health. She has led clinical operations and medical writing teams for more than two decades in both CRO and sponsor organizations. Ms. Meyers has authored documents across all phases of clinical development for pharmaceutical products as well medical devices, including regulatory dossiers and submissions. In addition, she has also led regulatory and clinical development, leading two oncology products to NDA submission and subsequent approval. Prior to her career in clinical research, Ms. Meyers practiced neuropsychology. In 2020, Ms. Meyers was honored to be named a Healthcare Businesswomen's Association Luminary in recognition of her 25+ years of service in Clinical Research.

Peter is a seasoned, medical communications, accounts leader and business developer with ~ 20 years of experience managing international teams, building accounts from the ground up, and developing strong client relationships with emerging biotechnology organizations to top-5 pharmaceutical corporations. He is considered a healthcare content development specialist and has personally developed digital assets, scientific narratives, slide presentations presented at the DHHS, strategic analyses and supported publications and other scientific deliverables. He has developed ground breaking educational agendas and initiatives that have led to the unique education of HCPs in a variety of therapeutic areas.

Lori Mouser is the Global Head of Medical Customer Engagement at Roche. She champions the success of field medical teams and medical information teams to advance medicine through their engagements with healthcare providers and patients. Leading medical engagement teams for over 18 years, Lori brings the experience from a range of therapeutic areas. She has US and Global experience and operates with a commitment to creating solutions through collaboration. Lori’s first MSL position was at Aventis (now Sanofi) where she quickly gravitated to leading MSL teams during her 12 years with the company. Joining the Roche organization at Genentech in 2012, Lori ultimately was responsible for the national US Oncology MSL and field leadership team.

Dr. Meg Richards has nearly 30 years' experience as an epidemiologist in the public health, biotech/pharmaceutical, and contract research sectors. Dr. Richards currently serves as Executive Director, Solutions, at Panalgo. Previously she was a Senior Research Leader in Real-World Evidence at Evidera/PPD, where she spent a total of 10 years. Dr Richards also worked for ICON plc (Mapi, PRA Health Sciences) for 3 years. Dr. Richards has time in service at Genzyme (now Sanofi) and Abbott Labs (now AbbVie) in Patient Safety & Risk Management. Dr. Richards has degrees in nutrition & epidemiology and completed a two-year tour of duty with the US Public Health Service within the Centers for Disease Control and Prevention (CDC).

Rob is a Director of Medical Information at Johnson & Johnson responsible for the overall leadership of the Heme Oncology Medical Information team. His team has a focus on developing responses to medical information requests from HCPs and the provision of medical review for scientific and promotional materials. In addition to his 17 years of pharmaceutical industry experience, Rob also has 11 years of experience as a practicing pharmacist in various pharmacy settings. Rob earned his Bachelor of Science in Pharmacy from Temple University, his Doctor of Pharmacy degree from Shenandoah University, and his MBA from Drexel University.

Ann Winter-Vann earned her PhD in Molecular Cancer Biology from Duke University, where she was a predoctoral fellow of the Howard Hughes Medical Institute. Following a postdoctoral position in the Pharmacology Department at UNC-Chapel Hill, Ann joined Whitsell Innovations, Inc., where she is now a senior writer and manager. She has extensive experience in clinical regulatory writing and also provides consultations and training in medical writing. Ann has co-taught a science writing course for first-year biomedical graduate students at UNC-Chapel Hill. Ann is a past president of the Carolinas chapter and the current President of the American Medical Writers Association (AMWA).

Alicia is Director and Team Lead for North America Oncology Medical Information at Pfizer Inc. Alicia has participated in the DIA Core Curriculum both as faculty and Chairperson, and in 2010 served as Chairperson for the DIA Annual March Med Comm Meeting. She has led the Fellow program for the DIA Med Comm Meeting from 2012 thru 2021. Alicia received her BS in Pharmacy from St. John’s University, and her PharmD from Albany College of Pharmacy. She spent 4 years at The University of Pittsburgh School of Pharmacy as a Nephrology Fellow and then as Assistant Professor of Pharmacy and Therapeutics. Alicia also worked in Medical Communications at Wyeth Pharmaceuticals and as Medical Director at CoMed Communications.

Ivy has 20+ years of experience in the pharmaceutical industry. She is a Principal Medical Information Lead at Genentech with experience across diverse therapeutic areas including Oncology, Rheumatology, Respiratory, Ophthalmology, Endocrinology, Neurology, Cardiovascular Disease, and various clinical conditions with an immunologic basis in pathophysiology. Prior to joining Genentech, she was a Clinical Pharmacist in General Surgery, Surgical Subspecialties, and Solid Organ Transplant at the University of California San Francisco (UCSF) Medical Center, and an Assistant Clinical Professor with the UCSF School of Pharmacy. Ivy received her PharmD from University of Tennessee Health Science Center.

“Dr. G” Gulati is a sought-after expert on health, trends, and innovation. Radical leaders looking to transform organizations into innovative powerhouses call on Dr. G to help think differently, escape the trap of mediocrity, and unleash creativity. Dr. G is the Founder of The Well Home, an interior wellness design clinic; and also the founder of Well Played, a non-boring storytelling studio. He has over 20 years of hands-on experience as an award-winning innovation executive for a number of globally recognized brands and products - both inside and out of healthcare. Dr. G received his MD and MPH from The George Washington University, and MBA from Johns Hopkins University.

Jennie G. Jacobson is President of Jacobson Medical Writing. She earned her BA from Swarthmore College, and PhD from Harvard University. Jennie was a post-doc at Upjohn Laboratories and the University of Michigan before realizing being a medical writer would allow her all the fun of interpreting data without having to generate it. She rounded out her education with two AMWA certificates, a certificate in Medical Writing from U Chicago, and CMPP certification. In her 24 years as a medical writer, Jennie has written publications in a wide array of therapeutic areas including oncology, neurology, health outcomes research, gene therapy, endocrinology, respiratory disease, autoimmune disease, ophthalmology, and gastrointestinal disease.

David Price, PhD has been employed with Eli Lilly and Company since 2011. David began as a Psychiatry Medical Science Liaison. David took the opportunity to diversify his MSL experience by transitioning to MSL roles supporting Urology as well as Musculoskeletal therapeutic areas. In 2014, David shifted to US Field Medical Operations and capability development across numerous therapeutic areas and MSL teams. Prior to his current role, David was a Global MSL Trainer in Lilly’s Office of Medical Professional Development. In 2018, David started his current position as a Field Medical Advisor providing operational leadership, strategic oversight and chief of staff responsibilities for Lilly’s US Bio-Medicines MSL program.

Rebecca Vermeulen, RPh, brings a variety of experiences to her role as VP of Strategy for Patients and Society, Product Development, at Hoffman La Roche. She has served in numerous functions including Medical Affairs, Clinical Research, Sales, Medical Communications, Medical Science Liaisons, Patient Partnership, Digital Health, and Six Sigma, in her 29 years of healthcare industry experience, and has been responsible for creating global standards for information exchange with healthcare professionals and patients. Rebecca is currently a board member for Patient Focused Medicines Development, Past Chair Board of Directors for the DIA, Chair Emeritus Corporate Board of Directors for the Healthcare Businesswomen’s Association.

Dan Benau, PhD, Director of Biomedical Writing Programs, Professor of Biomedical Writing at the University of the Sciences. Wyeth-Ayerst Research: Scientific Writer - Principal Medical Writer (1991 - 2001), Sanofi-Synthelabo: Medical Writing Project Leader (2001 - 2003), Freelance (2003 - 2008). DIA Professional Education, Development, Training Community (2004 - 2016), DIA Medical Writing Community (2003 - present). Other memberships: AMWA, RAPS. Interests: Systems approaches to medical writing, regulatory writing, medical writing technology, holistic integration of medical writing genres.

With nearly 20 years of experience in the healthcare and pharmaceutical industry, Amy has held various roles of increasing responsibility within the areas of Medical Affairs and Regulatory. As the current head of US Medical Affairs, she is responsible for developing, communicating and driving strategy and leading the organization to success with a prioritized focus on the design and delivery of MI and MSL programs. Prior to joining Ashfield, Amy spent more than 10 years at Johnson & Johnson supporting the biopharmaceutical business in the areas of Immunology, Infectious Diseases, Vaccines, Global Public Health, Strategic Customer Group (Market Access), Established Products Group, and the Research & Development areas.

Isabelle Widmer, MD is a life science consultant and coach based in Europe. Isabelle supports teams in both Fortune 500 companies and biotech to deliver global transformation programmes in Medical Affairs and Med Info. Combining an entrepreneurial mindset, analytical and project management skills with the ability to design and implement tailored solutions, Isabelle takes pride in proposing pragmatic, sustainable and cost-effective solutions. A published author, frequent conference presenter, recent Programme Director at Basel University in postgraduate education in pharmaceutical medicine and a Program Committee member for the DIA Annual European Medical Information and Communications Meeting she is passionate about continuing education.

Dr. Robin Winter-Sperry is currently the Global MSL Lead at Ipsen Biosciences in Cambridge, MA. Prior to joining Ipsen she was the Head of Global Field Based Medical Excellence and Insights at Sanofi Genzyme. Additionally Robin has extensive consulting experience as President of Scientific Advantage. She has been instrumental in Medical Affairs strategy and operations including mergers, transitions and Medical Affairs organizational design. She has pioneered the recognition of MSLs as a specialty in the biopharmaceutical and device industry and is responsible for creating and developing many of the industry’s leading Medical Affairs and Medical Liaison teams.

Dr. Biagi serves as Clinical Site Management Team Lead for UCB, Inc. She brings over 20 years of experience within the pharmaceutical industry. She has held many memberships and designations over the years including positions with the American Medical Writers Association and the Georgia Pharmacy Association. Dr. Biagi received her PharmD and Drug Information Residency from Mercer University.

Dr. Janet Gottlieb is the Executive Director of Medical Compliance Excellence, Material Review at AbbVie, where she is responsible for developing and training on global policies governing promotional and non-promotional materials. In her previous role, Dr. Gottlieb led the team responsible for the medical and scientific review of Company promotional materials where she had a direct role in the formation, expansion, and training of the centralized team. These advancements resulted in greater efficiencies via improved turnaround times, consistency in guidance, and enhanced communication. Dr. Gottlieb holds an undergraduate degree in Biological Sciences and Ph.D. in Medical Microbiology from the University of California, Irvine.

Dr. Kshatriya is author, speaker & medical communications expert with over 25 yrs industry experience. She has published book Recoding Scientific Publishing: Raising the Bar in an Era of Transformation, providing key insights into scientific publishing process. She is founder of Publication Practice Counsel, Truposha LLC, providing medical communication services to pharmaceutical, biotech & medical device companies. Prior to this, she has worked at Novartis Oncology, ALTANA Pharma, Aventis Pharmaceuticals, and DuPont Merck Pharmaceutical Company. She has extensive medical affairs experience, including publications, med education, med info, ad boards, etc, and expertise in corporate policy/SOPs, metrics, compliance & monitoring.

MaryKate Lesnevich is Director, Global Scientific Communications, I&I at Celgene Corporation. She has over 18 years of experience working in both the medical device and pharmaceutical industry. During that time, MaryKate has primarily focused on peer-reviewed publication planning related to abdominal surgery, dermatology, gastroenterology, neurology, and rheumatology. In her current role, MaryKate leads the global publication teams for neurology and gastroenterology at Celgene. MaryKate has a MS in Clinical Trial Management and is a Certified Medical Publication Professional (ISMPP CMPP™).

Emily Costerison is Compliance Manager within US Medical Affairs at Genentech. She has worked at Genentech since 2007 with a focus on communicating clinical information to healthcare professionals and managed care organizations and now supports compliance for her medical organization. Emily received her Doctor of Pharmacy degree from the University of Washington. She also completed a Pharmacy General Practice Residency and Drug Information Residency at Stanford Hospital & Clinics.

I have worked as a medical writer at both contract research organization and sponsor companies and have written clinical study reports, narratives, and protocols for all phases of drug trials; investigator brochures; safety documents; risk evaluation and mitigation strategy assessment reports; health hazard evaluations; briefing documents and responses to health authority questions; and marketing submission documents (including US, EU, Japan, and China). I have also managed vendors, overseen and planned regulatory submission packages, and acted as the subject matter expert for health authority inspections. I have presented on numerous regulatory medical writing topics at both local and national professional conferences.

Truc Dinh is an Associate Director in Global and US Medical Information at Gilead Sciences focused on Virology and COVID-19. She brings over 5 years of experience in Medical Information launch excellence, medical and promotional review, insights generation and cross-functional collaboration. She received a Bachelors degree in Public Health and Public Policy from the University of California, Berkeley and a Doctor of Pharmacy degree from the University of California, San Francisco with an emphasis on the Health Sciences and Policy Management pathway. She completed her postdoctoral fellowship in Medical Information with Gilead Sciences and the University of Southern California.

Dr. Stacey Follman has spent her 26-year pharmacy career at Pfizer including 15 years in the World-Wide Safety and Regulatory department in Safety Evaluation and Reporting and 11 years in Medical information. Formerly the Director, Student Affairs and currently Director, Global Content Management in Pfizer’s Global Medical Information Department . Dr. Follman has experience overseeing scholarly activities associated with approximately 10 APPE Pharmacy rotational students annually, the Student Summer Worker program and the recruitment and preceptorship of post-doctoral Fellows. In addition, she maintains internal/external partnerships, leading student/fellow initiatives with multiple scientific institutions.

Stacey Fung, PharmD is the Head of Global Medical Information at Gilead Sciences. Prior to joining Gilead, she held positions in the Medical Affairs departments of Genentech, Chiron Therapeutics and Protein Design Labs and has practiced in hospital and retail pharmacy settings. She is a seasoned presenter and has chaired meeting sessions at DIA workshops and annual meetings. She has authored several clinical, scientific, and pharmaceutical industry-focused articles. She received a BS in Biology from University of California Davis and PharmD from University of the Pacific. She received post-graduate training at the University of California San Francisco and a drug information residency at University of the Pacific.

Anand Kiran is Executive Vice President of R&D Solutions and Global Delivery, Indegene. He is one of the co-founders of the company. Anand is responsible for business solutions and execution of R&D Solutions (Clinical, Safety, Regulatory and Medical) for Pharmaceuticals/Lifesciences. His responsibilities include conceptualizing, developing and delivering portfolio solutions by bringing deep medical/scientific expertise and modern technologies; and exploring newer avenues to drive innovations and value for Indegene’s clients in the R&D space. With over 25 years of experience in clinical research, medical affairs, pharma sales, and marketing, Anand has been successful in managing products from development to commercialization.

Kelly T. Pincus, Pharm.D. Therapeutic Area Director, US Medical Information, Specialty, HIV and Classic and Established Medicines GlaxoSmithKline Kelly is the Therapeutic Area MI Director with GSK, supporting Specialty, HIV, and Classic and Established Medicines. She has over 20 years’ experience in the pharmaceutical industry, and has held several positions within GSK. Kelly received her Pharm.D. from Mercer University College of Pharmacy in Atlanta GA. She has also earned a Masters from the College of Business at Western Carolina University. Prior to joining industry, Kelly was an assistant professor in Pharmacy Practice at Creighton University in Omaha, NE.

Iris Tam, PharmD, FAMCP, is Senior Vice President & Head of Medical Affairs and HEOR at COEUS Consulting with over 30 years of experience in health care, including hospital pharmacy, managed care pharmacy, and the biopharmaceutical industry. In previous industry roles, she led Medical Affairs strategies and tactics that support market access, product value, and patient access, including accountabilities for medical communications, HEOR, AMCP dossiers, compendia submissions, guideline bodies engagement, and payer communications. From 2008 to 2021, Iris served on the AMCP Format Executive Committee which oversees the AMCP Format for Formulary Submissions for dossier development, including serving as the Chair for the last 3 years.

Ann is a Senior Knowledge Expert in McKinsey & Company’s Minneapolis Office. In her 10+ years at the Firm, she has served clients across the pharmaceutical industry, focused on medical topics including Chief Medical Officers, Medical Affairs, and real-world evidence. Ann leads McKinsey's medical service line and related internal knowledge efforts in Medical Affairs, Real World Evidence and other related topics. Prior to joining McKinsey & Company, Ann earned her M.D. from Johns Hopkins University School of Medicine and completed her residency in pediatrics at New York Hospital / Weill Cornell Medicine.

Ellen is the co-owner of Scientific Content Solutions, LLC and the sole proprietor of EW Associates, LLC. She was previously a director of medical communications with an agency. Ellen has experience with medical information-related documents (e.g., standard letters, FAQs, dossiers, escalated inquiries), continuing education articles, primary author publications, promotional review, payer materials, and advisory board meeting reports. As a member of AMCP Format Executive Committee, Ellen contributed to AMCP Format 4.1. She serves as a Clinical Assistant Professor at the University of Georgia College of Pharmacy. Since 2000, Ellen has been a Medical Advisor for the MS Foundation.

Dr. Winslow has 30 years of experience as a drug information pharmacist in a variety of settings. During his nearly 10 year tenure at GSK Medical Information, he directed several therapeutic areas. Dr. Winslow has been Global Director of Medical Information at Quintiles Transnational since 2006.

With 17 years of experience in medical writing working for US, European, and Chinese companies, Hongbo Zhu is a leading medical writing expert in China. When in the US, Hongbo had over a decade of experience at several US-based pharmaceutical and CRO companies on the East Coast (Parexel) and West Coast (Allergan). In addition, Hongbo has over 7 years of experience working in China for both MNCs (Boehringer Ingelheim) and a Chinese national pharma (Kelun). Currently, Dr. Zhu is Director, Head of China Medical Writing at Pfizer. Hongbo obtained his PhD in Biopsychology from the City University of New York in 2002, and he completed a post-doctoral fellowship at Cornell University before he joined the industry in 2003.

Elizabeth Brown is a Senior Director and TA Lead of Oncology Medical Writing at Merck & Co, Inc. near Philadelphia, PA. She has led regulatory projects and initiatives in the pharmaceutical industry for 20+ years. First as a laboratory scientist, then as a clinical researcher, and currently as a medical writer. Elizabeth brings a project and people management focus to her role as a regulatory medical writer and department leader. With this focus, she has developed a passion for developing people, advising teams and providing strategic guidance how to deliver efficient, effective, and high-quality documents.

Payal Desai earned a PharmD degree from the University of Sciences in Philadelphia. Dr. Desai worked in community practice before transitioning to a career in pharmaceutical industry. Over 20 years, Dr. Desai served at several pharmaceutical companies. In her current role at Janssen, she is the Integrated Evidence Team Lead and is responsible for generating the evidence generation plan within Medical Affairs. Previously, she was the Associate Director of Medical Information, where she was responsible for the successful launch of cardiovascular products, promotional review, and development of scientific responses. . She provides strategic medical support and participates in several cross-functional teams.

Carsten is an assistant professor of Medical and Computer Science at Brown University where he leads the Biomedical AI Lab, specializing in the development of data science and information retrieval techniques with the goal of improving patient safety, individual health and quality of medical care. Before coming to Brown, he studied artificial intelligence and machine learning at the University of Edinburgh, TU Delft and ETH Zurich. Carsten has authored over 80 conference and journal articles and is involved in several deep technology startups in the health sector that translate technological innovation to improved safety and quality of life for patients.

As a highly accomplished scientist with a strong background in project management, Dr. Rita Francis brings a wealth of expertise in the areas of research and development (R&D), technical and biomedical writing, scientific technology, and undergraduate and post-graduate education. A respected leader in the scientific and pharmaceutical industries, Rita has long been a trusted partner to this sector on matters related to product development and project management. Her strategic business vision is complemented by her scientific acumen, enabling her to bring a unique perspective to the projects she manages.

Kirsten Helmcke, PhD, RAC is an Associate Medical Writing Program Director at Astellas Pharma. She has led multiple global submissions in the areas of oncology and immunology/transplantation, with over 15 years of drug development experience across the pharmaceutical industry and academia.

Brooke has worked within the pharmaceutical industry for the past 9 years starting as an MSL and progressing through escalating field and home office leadership roles. Brooke has led Medical engagement strategies across 15 launches for both small and large molecules and across multiple therapeutic areas. Brooke is currently the Head of Medical Affairs Strategy and Operations for GSK

Tim Hylan has more than 25 years of experience in health care, biopharmaceuticals, government, and academia. Tim has an undergraduate degree from Lafayette College in Easton, PA and an MA and PhD in Economics from Penn State University. He was an Assistant Professor of Economics at St. John Fisher College in Rochester, NY. Tim has also worked at the CNA Corporation where he conducted HCP force planning analyses and Eli Lilly and Company where he was the Global Health Economist for Prozac In 1999, Tim joined Pfizer, Inc. as a Team Leader in Field Medical and assumed roles with increasing responsibilities over the years. In 2016, he assumed his current position as Lead for the Internal Medicine Field Medical Director Group.

Robert Jaramillo, PharmD, RPh is Head of Health Economics and Outcomes Research (HEOR) Field at Sunovion Pharmaceuticals Inc. Based in Salt Lake City, UT, he is responsible for overseeing the Sunovion Health Economics and Outcomes Research (HEOR) field team who work primarily with formulary and population decision makers across the United States. He has over 25 years of experience in formulary management and development, pharmacoeconomic analysis, health economics, pharmacy utilization management, benefit design, disease management and field team management. Prior to joining Sunovion, Robert held senior field roles at Forest Laboratories and Novartis pharmaceuticals. Other roles included, Pharmacy Director at Utah Public Employees Health

Monica Kwarcinski is currently the Vice President of Medical Affairs at Purdue Pharma. In this role Monica oversees Medical Information, MSLs, Medical Communications and Strategy, Health Economic and Outcomes Research, Epidemiology, and FDA Postmarketing Requirement studies. Prior to joining Purdue Pharma, Monica held various positions of increasing responsibilities within Abbott Laboratories Medical Affairs Department. She received her PharmD from Creighton University in Omaha, Nebraska followed by a Drug Information Residency University of North Carolina, Chapel Hill and Glaxo. Monica has 25+ years of industry experience and frequently speaks on topics related to industry medical communications compliance and department processes.

Tony is currently the Head of Scientific communications, Medical Review and Knowledge Management for Pharmacyclics, where he is responsible for all medical affairs strategic communications, training & education, and medical communication/information activities. With over 12 years of medical affairs experience, he has a specific focus and passion for optimizing the "pull through" of medical objectives and strategies in medcomm/scicomm initiatives and tactics, and building teams to demonstrate the ever expanding value of the scicomm/medcomm function. Prior to joining Pharmacyclics, Tony held roles of increasing responsibility and leadership at Abbvie, Novartis, Amgen, and completed a 2-year post-doc fellowship with Schering-Plough.

Greg has over 35 years of diverse biopharmaceutical experience in sales, sales leadership, marketing, leadership development, and learning development across multiple therapeutic areas including oncology, nephrology, neurology, inflammation, cardiology, anti-infectives. Most recently, Greg is currently Director of Commercial learning and Development for Neurelis. Greg began his career with Bristol Labs as a sales rep., then spent the majority of his career with Bayer, Amgen, and Biogen. Greg served in Marketing, then as a Sr. Dist. Sales Manager for 15 years before transitioning to the role of Assoc. Dir. of Training, then Dir. of Commercial Leadership Development, where he was responsible for building commercial leaders at all levels.

Sejal Patel has over 20 years of experience in medical information roles in various therapeutic areas within the pharmaceutical industry. Sejal received her Bachelor of Science in Pharmacy and Doctor of Pharmacy degrees from the University of North Carolina at Chapel Hill and completed a pharmacy practice residency at Mount Sinai Medical Center in New York. She began her career in hospital pharmacy prior to joining pharmaceutical industry. Sejal has experience as a medical science liaison and has served in various US and Global medical information roles at AstraZeneca and GlaxoSmithKline. She is currently the Vice President of Medical and Regulatory Affairs at Sprout Pharmaceuticals.

Michelle Quinlan is an Associate Director, Medical Information at Pfizer. Dr. Quinlan graduated from St. John’s University College of Pharmacy where she received both her Bachelor of Science and Doctor of Pharmacy degrees. Dr. Quinlan has 10 years of experience working within the pharmaceutical industry. Prior to joining Pfizer, Dr. Quinlan practiced pharmacy in both the community and hospital settings.

Amy Ruffolo is a Senior Manager in Immunology, Dermatology at AbbVie. She began her career as a Clinical Pharmacist within her local hospital system and joined AbbVie 4 years ago in Global Medical Communications, first supporting Specialty before joining Immunology. She currently leads the Dermatology team, most recently co-leading and supporting two new major product launches. She also recently led the department’s first ever Health Care Provider Virtual Advisory Board to gain customer feedback, and presented findings at DIA MASC 2020. Amy obtained her bachelor’s degree in biology from the University of Wisconsin-Parkside and her PharmD degree from the University of Wisconsin-Madison.

Jim joined Merck in April 2019, as the Chief of Staff & Head, US MA Oncology Field Alignment, where he is responsible for the continuous development and improvement of cross-functional alignment, integrated field medical planning, and scientific excellence. Prior to Merck, Jim held various leadership roles of increasing responsibility at UCB Biosciences and Novartis including Field Medical Affairs, Medical Operations, Global Medical Affairs, Global Regulatory Affairs, and most recently, as Ecosystem Lead within the Neurology Integrated Matrix Team. Jim began his professional career as a management consultant with Accenture. Jim holds a MS & PhD in chemical/biomedical engineering from Georgia Tech and an international MBA from Arizona State.

With a career spanning more than 30 years in the pharmaceutical industry, Mr. Sibley has extensive experience across regulatory writing, consulting, and regulatory project leadership roles. He has successfully supported projects from discovery through approval and life cycle management. These include significant roles in more than 75 submissions and, in several cases, leading the entire submission team overseeing all documentation from Modules 1 through 5. Mr. Sibley drives the expansion of the company’s submission leadership and consulting capabilities in guiding clients to successful clearance of regulatory milestones.

Kirk Taylor, MD is a senior executive in the pharmaceutical industry with over 23 years of experience leading global teams, championing late phase development, and transforming medical departments. His breadth of industry knowledge stems from his roles as Chief Medical Officer, Chief Strategy Officer and Senior Vice President Medical Strategy and Operations. He has successfully restructured medical departments in major pharmaceutical companies as well as managed $100MM budgets including operational expenses. Kirk’s leadership portfolio includes cross-functional teams in the U.S., Northern Europe, Canada, Asia, Latin America, and the Middle East. He has successfully managed teams of 200 employees focused on global execution and alignment

Kay Uttech is VP for Strategic Initiatives at Indegene working with companies to build and optimize medical affairs services. She has more than 20 years’ experience in the pharmaceutical and medical device industry. Kay has held roles in Medical Affairs as a MSL and leading MSL teams in North America. Additionally, she has also held other responsiiblities in Medical Communication and Information; development of global scientific knowledge management systems; grants for ISS and medical education; and promotional review. Her current work is focused on leveraging technology to drive efficiency that optimizes the medical and scientiifc expertise of Medical Affairs teams.

Danielle Janiszewski is Senior Manager, US Medical Information at Incyte Corporation, where she is responsible for leading the development of written medical materials, including medical information letters and AMCP dossiers. She also serves as a medical reviewer of promotional materials. Danielle received a Bachelor of Science degree in Pharmaceutical Product Development from West Chester University and a Doctor of Pharmacy degree from Thomas Jefferson University. She also completed a post-doctoral industry fellowship in Global Medical Affairs with Cubist Pharmaceuticals.

Kim Jochman is a Senior Director, Medical Writing at Merck. She has a Ph.D in biological psychology and has been a regulatory medical writer since 2007, with experience across a broad range of document types, development phases, and therapeutic areas. Kim is passionate about training, mentoring, and process optimization. In her current role, she leads a variety of training, technical, and strategic initiatives to maximize the quality and efficiency of the authoring process. These include developing & leading training programs for early career Medical Writers, conducting industry trainings on lean authoring & data interpretation, and supporting technology initiatives at Merck.

Dr. Anderson is a medical writer and instructional designer with 12 years of experience in writing various types of medical education peices for scientific audiences including MDs, PharmD, PhDs, medical science liaisons, and managed care directors as well as sales reps who call on these personnel. Dr. Anderson has earned an Associate in Applied Science in Medical Laboratory Technology from Mercer County College, a Bachelors of Science in Biology from Rider University, a Masters in Biomedical Writing from the University of the Sciences in Philadelphia, and a PhD in Instructional Design from Capella University. Dr. Anderson is also certified as a specialist in hematology from the American Society of Clinical Pathologists.

Leena is Director, Medical Information at Janssen Pharmaceutical Companies of Johnson & Johnson. She has been with J&J since 2000. In her current role, Leena is responsible for leading global content and Innovation for Janssen’s Medical Information community. In the past Leena has managed Medical Information teams across various TAs including Metabolism, Infectious Disease, Pain, Women’s Health, Urology products. Leena is responsible for defining processes, developing strategies, integrating technology to create innovative customer response solutions and executing projects. Leena earned her Doctor of Pharmacy degree from Rutgers College of Pharmacy, New Jersey, in 2000.

Nancy is President of Illyria Consulting Group, Inc., which specializes in the creation of eCTD-compliant documents. As a DIA MW Community member, she chaired the E3 committee, which facilitated a Q & A to ICH E3, and the Education committee. She also serves on the community's extended core committee. She mentors writers through AuthorAid, is an active AMWA member (twice chapter president of Northern California chapter), teaches the "Electronic Common Technical Document" Workshop at AMWA conferences, and has conducted research showing how medical writers contribute to regulatory documents. She earned Medical Writing Certification (MWC) in 2015.

Sameer heads a business unit at Indegene focusing on services to Medical Affairs. He is responsible for the overall value proposition, capability mix, resourcing, external partnership, key client wins) to increase market penetration and drive business growth. He drives the overall P&L through sales and marketing efforts, capability building, innovation and delivery. He is responsible for managing a team of professionals based in multiple geographies with a mandate to grow Indegene’s business across service lines. Sameer has over 22 years of experience both in the pharmaceutical industry as well as on the services side. Sameer is an MBA in Marketing with a Bachelor’s degree in Chemical Technology.

Dr Marsh joined GSK on January 16, 2020 as the Director Medical Engagement and Communications. Most recently, she served at HEMA Biologics as the Director of Medical Affairs, Medical Information and Scientific Communication for HEMA Biologics, LLC from 2017-2020. Combining over 25 years of both clinical pharmacy and industry medical affairs experience, including 8+ years in leadership roles with globalization projects, Dr Marsh enjoyed working early in her career in ambulatory care and adult medicine inpatient settings, serving as adjunct faculty with Colleges of Pharmacy (UGA, USC, and Auburn). She began her career in industry GSK 19 years ago and since that time, continued opportunities working in a variety of medical affairs roles w

Jennifer Park is a Global Content Manager at Sanofi working in the Global Medical Information organization with a focus in Consumer Healthcare. She received her Pharm.D. from Rutgers University. Prior to joining Sanofi, Jennifer completed a two-year fellowship in Medical Information with the Rutgers Pharmaceutical Industry Fellowship program. She serves as a preceptor for Rutgers fellows and pharmacy students in her department.

Poonam is currently a Team Lead within the Global Scientific Content group at Merck based in Kenilworth, NJ. She has global responsibility across the entire General Medicines portfolio with a large team covering key products. Most recently, Poonam was at Celgene in the Strategic Medical Communications and Innovation group. Prior to this, Poonam worked at Sanofi in the Medical Information Department for 12 years, at JNJ in the Global Competitive Intelligence group for 3 years, and at Parke-Davis in the MI Department for 3 years. She has 25 years of experience in Pharma and has 2 publications regarding Social Media and Medical Information Trends. Poonam chaired the 2019 DIA MASC meeting is now involved with DIA Annual.

Sarah Jarvis leads our Global Medical Affairs consulting space at ZS. Based now in San Francisco, California, Sarah has worked in the lifesciences industry for over 25 years and has focused exclusively on working with medical affairs clients for the past 15 years at ZS. ZS has worked with more than 100 companies' Medical Affairs organizations. Sarah also previously worked at Genentech in a variety of different roles on products that spanned therapy areas and phases of the lifecycle. With COVID acting as an accelerator on the medical function, ZS is partnering with clients to support the growth and change needed to meet global demands - in the field and in headquarters - through strategy, advanced analytics, and operations projects.

Lexi Kaplin is co-founder and leads product development at conversationHEALTH through her background in engineering, and experience in product management from her previous company. Her core focus is bridging the gap between new technologies and applications in the market. She was part of two incubator programs, the Next 36 and the Queen’s Innovation Connector, where she learned from Canada’s top entrepreneurs and completed MBA level classes from institutions such as MIT, Harvard and Georgetown. conversationHEALTH’s SaaS platform enables enterprise life-science companies to create conversational AI solutions to engage its consumers, patients and doctors in real time 24/7/365.

Robin Watts is a Program Manager/Principal Medical Writer with the Medical Writing and Healthcare Communications team at Evidera, a business unit within PPD. Robin has over 20 years of medical information and medical writing experience. Her experience includes authoring and reviewing standard and global response letters, custom response letters, frequently asked questions, ad hoc responses, Academy of Managed Care Pharmacy (AMCP) dossiers, and slide decks in a variety of therapeutic areas. Prior to joining Evidera and PPD, she practiced pharmacy in the community setting. Robin earned both her Bachelor of Science in Pharmacy and Doctor of Pharmacy degrees from the University of North Carolina at Chapel Hill.

Founder and president of Whitsell Innovations, Inc., a medical writing firm headquartered in Chapel Hill, NC, Ms. Whitsell has over 25 years of experience, specializing in global submission strategy, regulatory medical writing, emerging technologies, and data visualization. Prior to founding WI, Ms. Whitsell was the assistant director of preclinical & clinical development at Inspire Pharmaceuticals and a team lead at GlaxoWellcome. She has degrees in biophysics and physics from Miami University and interned at Los Alamos National Laboratory.